Form 4: Senti Biosciences Officer's Tax Withholding

Kanya Rajangam, President & Chief Medical & Development Officer of Senti Biosciences, reported a disposition of 1,384 common shares for tax withholding purposes.

Summary

• Kanya Rajangam, President & Chief Medical & Development Officer of Senti Biosciences, Inc. (SNTI), reported a transaction on February 2, 2026.
• The transaction involved the disposition of 1,384 shares of common stock.
• These shares were withheld by Senti Biosciences to satisfy income tax withholding and remittance obligations related to the net settlement of time-based restricted stock unit awards.
• This disposition was not an open market sale.
• Following this transaction, Kanya Rajangam beneficially owns 85,600 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, non-discretionary transaction for tax purposes related to equity compensation, with no impact on the company's operational or financial performance.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that the disposition of shares for tax withholding purposes upon the vesting of restricted stock units is a common and routine occurrence for executives receiving equity compensation across various industries, particularly in the biotechnology sector where equity incentives are prevalent.

Comparison to Industry Standards

• StockSavvy.ai notes that tax withholding upon the vesting of restricted stock units is a standard practice for equity compensation across global benchmarks, including major U.S. and international companies. This mechanism ensures compliance with tax obligations without requiring the executive to fund the tax liability out-of-pocket, aligning with common corporate governance practices for executive compensation.

Stakeholder Impact

• Shareholders: Minimal direct impact as this is a routine tax-related transaction and not a discretionary sale by an insider.

Key Dates

Recommendation

This Form 4 reports a routine tax withholding transaction related to restricted stock unit vesting and does not indicate a discretionary sale or provide new information that would alter the fundamental investment thesis for Senti Biosciences. Therefore, a 'hold' recommendation is appropriate based solely on this filing.

Keywords

Senti Biosciences, SNTI, Form 4, Insider Transaction, Tax Withholding, Restricted Stock Units, Kanya Rajangam